Modulation of B-type natriuretic peptide by pharmacologic therapy, including the angiotensin receptor blocker valsartan, has been shown to improve outcomes in patients with chronic heart failure ...

The US Food and Drug Administration recently approved a point-of-care B-type natriuretic peptide assay to be used in the diagnosis of HF. Nesiritide, a synthetic B-type natriuretic peptide ...

Brain natriuretic peptide (BNP), first discovered in porcine brain, is principally produced by the heart. Unlike atrial natriuretic peptide (ANP), BNP is largely derived from the ventricles.

the researchers used cryo-electron microscopy (cryo-EM), computer modeling and other advanced techniques to determine the high-resolution structure of the atrial natriuretic peptide receptor, also ...

Emerging research highlights the cardiovascular benefits of popular anti-obesity medications, such as GLP-1-based therapies.